No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: No differences in survival in patients with esophageal cancer treated with neoadjuvant chemotherapy or chemoradiotherapy followed by esophagectomy

byTeddy Guo

April 22, 2021

in StudyGraphics

Reading Time: 1 min read

Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation

RelatedReports

Incidence of esophageal cancer subtypes vary drastically globally and by gender

Chronic Disease

Active Surveillance vs Standard Surgery Post-Neoadjuvant Chemoradiotherapy for Esophageal Cancer

March 24, 2025

StudyGraphics

#VisualAbstract: Atezolizumab Does Not Improve Outcomes in High-Risk Locally Advanced Head and Neck Squamous Cell Carcinoma

March 24, 2025

Hybrid minimally invasive esophagectomy associated with lower complication rates compared to open esophagectomy

Gastroenterology

Perioperative chemotherapy improves survival in esophageal cancer

March 6, 2025

StudyGraphics

#VisualAbstract: Perioperative Chemotherapy is Superior to Preoperative Chemoradiotherapy in Esophageal Cancer

February 7, 2025

Combined MRI and NIH stroke scores may predict stroke prognosis

Levetiracetam not clinically effective nor cost-effective compared to valproate for newly diagnosed generalized or unclassified epilepsy

Physical therapy reduces pain in adults with knee osteoarthritis

Web-based intervention of self-directed strengthening exercises improved pain and functional capacity for patients with osteoarthritis

#VisualAbstract Ivosidenib or enasidenib combined with intensive chemotherapy were well-tolerated and showed encouraging clinical activity in newly diagnosed mIDH1/mIDH2 acute myeloid leukemia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports